BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tuta M, Boc N, Brecelj E, Peternel M, Velenik V. Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure. World J Gastrointest Oncol 2021; 13(2): 119-130 [PMID: 33643528 DOI: 10.4251/wjgo.v13.i2.119]
URL: https://www.wjgnet.com/1007-9327/full/v13/i2/119.htm
Number Citing Articles
1
Rongbo Wen, Leqi Zhou, Siyuan Jiang, Hao Fan, Kuo Zheng, Yue Yu, Xianhua Gao, Liqiang Hao, Zheng Lou, Guanyu Yu, Fu Yang, Wei Zhang. DSTN Hypomethylation Promotes Radiotherapy Resistance of Rectal Cancer by Activating the Wnt/β-Catenin Signaling PathwayInternational Journal of Radiation Oncology*Biology*Physics 2023; 117(1): 198 doi: 10.1016/j.ijrobp.2023.03.067
2
Zhou Ma, Ling Tan, Zi-lin Liu, Ling-han Tang, Jiangwei Xiao. Total Neoadjuvant Therapy or Standard Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-AnalysisSSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3941038
3
Zhou Ma, Ling Tan, Zi-lin Liu, Jiang-wei Xiao. Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysisFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.911538
4
M Chen, H Lin, J Zhang, X Pang, X Fan, S Luo, Z Liu, H Hu, S Lai, Y Hou, L Kang, L Huang. Presence and clinical significance of acellular mucin pools in resected rectal cancer with pathological complete response after pre‐operative chemoradiotherapyHistopathology 2022; 81(5): 569 doi: 10.1111/his.14795
5
K S Poojashree, Tasneem Rushdi, A Krishnan Raju, Devender Reddy Boja. Clinical and dosimetric comparison of acute bowel toxicities in carcinoma rectum patients receiving neoadjuvant chemoradiotherapy by using standard 3DCRT VS IMRTInternational journal of health sciences 2022; : 5171 doi: 10.53730/ijhs.v6nS1.6026
6
Mark Donnelly, Odhrán K Ryan, Éanna J Ryan, Ben Creavin, Mary O’Reilly, Ray McDermott, Rory Kennelly, Ann Hanly, Seán T Martin, Des C Winter. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trialsBritish Journal of Surgery 2023; 110(10): 1316 doi: 10.1093/bjs/znad177
7
Carolina Vigna, Ana Sofia Ore, Anne Fabrizio, Evangelos Messaris. Evaluation of racial/ethnic disparities in surgical outcomes after rectal cancer resection: An ACS-NSQIP analysisSurgery in Practice and Science 2024; 17: 100248 doi: 10.1016/j.sipas.2024.100248
8
Guodong Yang, Yu Cao, Xinyi Yang, Te Cui, Nicole Zian Vi Tan, Yuen Kai Lim, Yu Fu, Xinren Cao, Aanchal Bhandari, Mikhail Enikeev, Sergey Efetov, Vladimir Balaban, Mingze He. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies – Spotlight on prostate and colorectal cancerExperimental and Molecular Pathology 2024; 137: 104904 doi: 10.1016/j.yexmp.2024.104904
9
Qingbin Wu, Jiahao Zhou, Jun Huang, Xiangbing Deng, Changtao Li, Wenjian Meng, Yazhou He, Ziqiang Wang. Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysisBritish Journal of Surgery 2023; 110(7): 784 doi: 10.1093/bjs/znad120
10
Austin Fan, Beiqun Zhao, Peter Vu, Benjamin Abbadessa, Nicole Lopez, Samuel Eisenstein, Sonia Ramamoorthy, Shanglei Liu. Increased Pathologic Downstaging with Induction versus Consolidation Chemotherapy in Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy—A National Cancer Database AnalysisJournal of Clinical Medicine 2024; 13(3): 781 doi: 10.3390/jcm13030781